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esponsibility of Xi’aAbstract Two phenylethanoid glycosides, acteoside and forsythoside B, were ﬁrst isolated from
the traditional Chinese herb Callicarpa peii H.T. Chang. The interaction between the two
phenylethanoid glycosides and bovine serum albumin (BSA) was investigated by ﬂuorescence,
UV–vis absorbance and circular dichroism (CD). The results showed that the quenching
mechanism in the drug–BSA binary systems was a combination of static quenching and non-
radiative energy transfer. Displacement experiments conﬁrmed that the drug bound to the site I of
BSA. UV–vis and CD measurements indicated that the binding of the drug to BSA induced
conformational changes in BSA.
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Phenylethanoid glycosides are an interesting group of phenolic
natural products that are widely distributed in Callicarpa plants.
Structurally, they are characterized by a hydroxyphenylethyl
moiety attached to b-glucopyranose through glycosidic linkage.ersity. Production and hosting by E
.001
39358047.
du.cn (A.-Z. Wu),
)
n Jiaotong University.Such compounds possess broad pharmacological activities, very
low toxicity and good safety features [1].
BSA consists of 583 amino acids with 20 tyrosyl residues,
which is largely a-helical and contains three structurally
homologous domains (I–III). Each domain in turn is the
product of two sub-domains (A and B). The principal binding
sites with different speciﬁcities are referred to as site I and site
II [2], and located in the hydrophobic cavities of sub-domains
IIA and IIIA, respectively. Many drugs speciﬁcally bind to
serum albumin, such as phenylbutazone in site I and ibuprofen
in site II [3].
Spectral methods are powerful tools for the study of drug
binding with proteins since they allow nonintrusive measure-
ments of substances in low concentration [4]. Studies on the
binding of drugs to albumins may provide information oflsevier B.V. All rights reserved.
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of drugs, and become an important research ﬁeld in life
sciences. In this work, two glycosides, acteoside and forsytho-
side B, were ﬁrst isolated from the traditional Chinese herb
Callicarpa peii H.T. Chang, and to the best of our knowledge,
it was also the ﬁrst investigation about the interaction between
phenylethanoid glycosides and serum albumin. This study is
expected to provide a qualitative understanding of the binding
effect of acteoside or forsythoside B with BSA.2. Experimental
2.1. Materials and apparatus
BSA (Fraction V) was obtained from Sigma Chemical Com-
pany. Acteoside and forsythoside B were isolated by the
authors from Callicarpa peii H.T. Chang. Their purities were
over 98% by normalization of the peak areas detected by
HPLC-UV. Steady-state ﬂuorescence measurements were car-
ried out through a F2500 spectrophotometer. UV–vis and CD
measurements were performed with a UV1000 UV–vis spec-
trophotometer and Chirascan spectropolarimeter, respectively.
2.2. Spectroscopic measurement
Fluorescence measurements were carried out keeping the
concentration of BSA ﬁxed at 4.0 107 M and the drugs
varied from 0 to 3.5 105 M. The excitation wavelength was
280 nm and the intrinsic ﬂuorescence emission spectra of BSA
were recorded at three different temperatures (298, 304 and
310 K). Absorption spectra were recorded at 0.5 nm intervals
keeping the concentration of BSA ﬁxed at 1.0 105 M and
the drugs varied from 0 to 4.0 105 M. CD spectra were
recorded at 0.5 nm intervals under constant nitrogen ﬂush
keeping the concentration of BSA ﬁxed at 2.0 106 M and
the molar ratio of the drugs to BSA varied as 0:1 and 10:1.
Displacement experiments were performed keeping phenylbu-
tazone and ibuprofen as site probes of sites I and II, respectively.
The concentrations of BSA and the probe were ﬁxed at
1.13 106 M. Then the ﬂuorescence titration experiments in
the presence of phenylbutazone or ibuprofen were performed.Fig. 1 (A) Effects of acteoside on the ﬂuorescence spectra of BSA
ﬂuorescence (a) with the absorption spectra (b) of acteoside. c(BSA)¼3. Results and discussion
3.1. Fluorescence quenching of BSA by drugs
As shown in Fig. 1A, upon the addition of the drug into BSA
solution, the ﬂuorescence intensity of BSA at around 340 nm
regularly decreased and the ﬂuorescence intensity decreased
tardily in each titration curve which indicated that the drug
could interact with BSA and the gradual saturation of the
BSA binding site. Furthermore, the maximum wavelength of
BSA shifted from about 340 to 347 nm after the addition of
the drugs. A redshift of the emission peak was observed when
the tryptophan residue of BSA was placed in a more hydro-
philic environment [5]. The reason may be that the glycosyl
groups of two phenylethanoid glycosides resulted in the
increasing polarity of microenvironment around the trypto-
phan residue of BSA after the addition of the drug. A
concomitant increase of emission at about 460 nm is the result
of the radiationless energy transfer between the tryptophan
residue and the drug bound to BSA. The occurrence of an
isosbestic point at about 423 nm indicated that the quenching
of protein ﬂuorescence depended on the formation of
acteoside–BSA and forsythoside B–BSA compounds.
In order to determine the possible quenching mechanism of
the drug binding to BSA, the ﬂuorescence quenching constants
are usually analyzed by the Stern–Volmer equation [6] and the
results are listed in Table 1. The values of Kq decrease with
rising temperature, and are larger than the limiting diffusion
constant Kdiff (2.0 1010 M1 s1) [7], which suggests that the
possible quenching mechanism is a static quenching process
accompanied with the formation of complexes, while dynamic
collision could be negligible.
Because the concentrations of drugs were far more than
that of BSA, the double logarithm equation used to calculate
the binding constant Ka and the number of binding sites n are
reasonable for a static quenching process (Table 1) [8]. The Ka
of acteoside with BSA is larger than that of forsythoside B
with BSA, which may be because forsythoside B has one
additional apiose group that is unfavorable for the binding of
this drug with BSA. Our previous experimental results [9]
reported that the Ka of cistanoside F binding to BSA is
4.36 104 M1 at 298 K, less than that of phenylethanoidin Tris–HCl buffer of pH 7.40. (B) Spectral overlap of BSA
c(acteoside)¼1.0 105 M.
Table 1 Thermodynamic parameters between the drugs and BSA at different temperatures.
Drugs T (K) Kq ( 1012 M1 s1) Ka ( 105 M1) n DH (kJ/mol) DS (J/mol K) DG (kJ/mol)
Acetoside 298 6.99 6.83 1.22 7.24 72.78 14.46
304 6.67 7.72 1.24 14.88
310 6.39 8.87 1.25 15.33
Forsythosides B 298 5.35 2.20 1.08 31.63 150.42 13.24
304 4.47 3.26 1.20 14.01
310 3.36 6.88 1.29 15.04
Table 2 Binding constants of drugs to BSA before and after the addition of site probe at 298 K.
Drugs Ka (M
1) without the site probe Ka (M
1) with phenylbutazone Ka (M
1) with ibuprofen
Acetoside 6.83 105 1.91 104 4.83 104
Forsythoside B 2.20 105 8.24 104 2.13 105
Fig. 2 UV–vis absorbance spectra of BSA in the presence of (A) acteoside and (B) forsythoside B. Curve a: c(BSA)¼0.0;
c(drug)¼1.0 105 M, curves b–j: c(BSA)¼1.0 105 M, c(drug)¼0, 0.5 105, 1.0 105, 1.5 105, 2.0 105, 2.5 105,
3.0 105, 3.5 105, and 4.0 105 M. The inset shows the relationship of absorbance spectra maximum wavelength about 278 nm
and the molar concentration ratio of the drug to BSA.
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hydrophobic phenylethyl moiety that is favorable for the drug
binding to BSA. n is approximately equal to 1, indicating that
the drugs can be stored and carried by BSA under physiolo-
gical conditions via formation of the molar concentration
ratio 1:1 complexes. The facts DGo0, DH40 and DS40
indicate that the drug binding to BSA is a spontaneous inter-
molecular reaction. The positive DH and DS values are
frequently taken as mainly entropy driven while enthalpy is
unfavorable for it. Therefore, hydrophobic forces between
aromatic rings of the drugs and hydrophobic pocket of BSA
play a major role in the binding process [10].
To determine the speciﬁcity of the drug binding, competi-
tion experiments were performed with phenylbutazone and
ibuprofen. The results (Table 2) showed that phenylbutazone
(site I) gave a signiﬁcantly higher displacement of drugs
than ibuprofen (site II) after the addition of the siteprobes, suggesting that the drug binding site on BSA is the
hydrophobic pocket of site I, which is the main binding site for
the drugs binding to BSA through hydrophobic forces [11].3.2. Energy transfer from BSA to drugs
According to Fo¨rster’s non-radiative energy transfer theory
(FRET), if an acceptor can absorb the emitted ﬂuorescence
from a donor, energy may be transferred from the donor to
the acceptor. The overlap between the BSA emission spectra
and the absorption spectra of the drugs (Fig. 1B) means non-
radiative energy transfer occurs between the drugs and BSA.
Thus, the quenching mechanism in the drug–BSA binary
systems is a combination of static quenching and non-
radiative energy transfer. Using the FRET, the donor-to-
acceptor distance r was 3.13 nm and 2.97 nm for the binding
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Fig. 3 Circular dichroism spectra of (A) acteoside–BSA and (B) forsythoside B–BSA systems at pH¼7.40. Concentration ratios of
acteoside or forsythoside B to BSA are 0:1 and 10:1 (from curves a and b), respectively.
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result showed that forsythoside B is nearer to the tryptophan
residue of BSA than acteoside, which is in accordance with the
result of UV–vis absorption spectra (vide infra). Both r values
were less than 8 nm, indicating that the energy transfer from
BSA to the drug occurs with high possibility [12].
3.3. Conformation investigations
To further investigate whether any conformational changes of
BSA molecules occurred in the binding reaction, UV–vis and
CD spectra of BSA were measured. UV–vis spectra (Fig. 2)
showed that the absorption peaks at 278 nm had a slight red-
shift toward long wavelengths with increasing addition of the
drug, which may be the result of the increase of conjugation
around the chromophore of BSA due to the speciﬁc interac-
tion between the drugs and BSA [13]. The absorption peak of
acteoside shifted from 278 to 280 nm and that of forsythoside
B shifted from 278 to 280.5 nm, which showed that the
microenvironments around the chromophore of BSA were
more affected by forsythoside B than acteoside at the same
drug concentrations. CD spectra (Fig. 3) exhibited that the
band intensity of BSA decreased in the presence of the drugs
without signiﬁcant shift of the peaks, indicating that the
structure of BSA after the addition of the drugs is also
predominantly a-helix. The a-helix contents of BSA were
calculated to be 55.67% in free BSA, 51.88% for acteoside and
52.39% for forsythoside B [14] in bound form at molar ratio
of drug to BSA 10:1, respectively, which may be the result of
binding constant Ka of acteoside with BSA being larger than
that of forsythoside B with BSA. A small decrease of a-helix
percentage indicated the drugs bound with BSA, which
induced slight unfolding of the constitutive polypeptides of
BSA and increased the exposure of some hydrophobic regions
previously buried.4. Conclusions
Based on the above analyses, two relationships may exist in
the interaction of phenylethanoid glycoside with BSA: (1) the
increase of sugar numbers among phenylethanoid glycosides is
unfavorable for the drug binding to site I of BSA throughhydrophobic interaction due to the increase of drug polarity
and volume, and (2) hydrophobic phenylethyl moiety in the
drugs is favorable for the drug binding to BSA through
hydrophobic interaction. In conclusion, the binding interac-
tion of drug with BSA was enhanced by less sugar groups and
more aromatic rings; however, the effect of hydroxyl and drug
volume was not negligible.Acknowledgments
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